Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior Journal Article


Authors: Váradi, A.; Marrone, G. F.; Eans, S. O.; Ganno, M. L.; Subrath, J. J.; Le Rouzic, V.; Hunkele, A.; Pasternak, G. W.; McLaughlin, J. P.; Majumdar, S.
Article Title: Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior
Abstract: 3-Iodobenzoyl naltrexamine (IBNtxA) is a potent analgesic belonging to the pharmacologically diverse 6β-amidoepoxymorphinan group of opioids. We present the synthesis and pharmacological evaluation of five analogs of IBNtxA. The scaffold of IBNtxA was modified by removing the 14-hydroxy group, incorporating a 7,8 double bond and various N-17 alkyl substituents. The structural modifications resulted in analogs with picomolar affinities for opioid receptors. The lead compound (MP1104) was found to exhibit approximately 15-fold greater antinociceptive potency (ED50 = 0.33 mg/kg) compared with morphine, mediated through the activation of kappa- and delta-opioid receptors. Despite its kappa agonism, this lead derivative did not cause place aversion or preference in mice in a place-conditioning assay, even at doses 3 times the analgesic ED50. However, pretreatment with the lead compound prevented the reward behavior associated with cocaine in a conditioned place preference assay. Together, these results suggest the promise of dual acting kappa- and delta-opioid receptor agonists as analgesics and treatments for cocaine addiction. © 2015 American Chemical Society.
Keywords: opioid analgesics; delta; kappa; cocaine addiction; ibntxa; mp1104
Journal Title: ACS Chemical Neuroscience
Volume: 6
Issue: 11
ISSN: 1948-7193
Publisher: American Chemical Society  
Date Published: 2015-11-18
Start Page: 1813
End Page: 1824
Language: English
DOI: 10.1021/acschemneuro.5b00153
PROVIDER: scopus
PMCID: PMC4651729
PUBMED: 26325040
DOI/URL:
Notes: Export Date: 2 December 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gavril W Pasternak
    414 Pasternak
  2. Gina   Marrone
    14 Marrone
  3. Amanda Joy Hunkele
    17 Hunkele